FSCN1 Antibody

Fascin Actin-Bundling Protein 1, Mouse Anti Human
Cat. No.
BT18463
Source
Synonyms
Strongylocentrotus Purpuratus, actin-bundling protein, FAN1, HSN, SNL.
Appearance
Sterile filtered colorless solution.
Purity
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
FSCN1, an actin-bundling protein, plays a crucial role in providing rigidity to filopodial bundles. This rigidity is essential for efficiently pushing the membrane forward during processes like cytoskeleton remodeling and cell migration. This protein is involved in gathering actin filament bundles found in cellular structures such as microspikes, membrane ruffles, and stress fibers. While largely absent from normal epithelial cells, FSCN1 is upregulated in various human carcinomas. This increased expression is clinically associated with a poor prognosis. FSCN1 is abundantly expressed in neurons, glial cells, and endothelial cells.
Physical Appearance
The product is a sterile filtered solution, colorless in appearance.
Formulation
The antibody is supplied at a concentration of 1mg/ml in a buffer solution containing PBS at a pH of 7.4, 10% Glycerol, and 0.02% Sodium Azide.
Storage Procedures
For short-term storage (up to 1 month), store the antibody at 4°C. For extended storage, it is recommended to store at -20°C. Avoid repeated freeze-thaw cycles to maintain antibody stability.
Stability / Shelf Life
The antibody has a shelf life of 12 months when stored at -20°C and 1 month when stored at 4°C.
Applications
The FSCN1 antibody has undergone rigorous testing in various applications, including ELISA, Western blot analysis, Immunocytochemistry/Immunofluorescence (ICC/IF), and Flow cytometry, to ensure its specificity and reactivity. However, as optimal working dilutions may vary depending on the specific application and experimental conditions, it is recommended to perform titration experiments to determine the optimal working dilution for your particular application.
Synonyms
Strongylocentrotus Purpuratus, actin-bundling protein, FAN1, HSN, SNL.
Purification Method
FSCN1 antibody was purified from mouse ascitic fluids by protein-A affinity chromatography.
Type
Mouse Anti Human Monoclonal.
Clone
PAT13D2AT.
Immunogen
Anti-human FSCN1 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human FSCN1 protein 1-493 amino acids purified from E. coli.
Ig Subclass
Mouse IgG2b heavy chain and k light chain.

Product Science Overview

Introduction

Fascin Actin-Bundling Protein 1 (FSCN1) is a highly conserved actin-binding protein that plays a crucial role in the organization of the actin cytoskeleton. It is known for its ability to cross-link F-actin microfilaments into tight, parallel bundles, which is essential for various cellular processes such as motility, adhesion, and migration .

Gene and Protein Structure

The FSCN1 gene is located on chromosome 7p22.1 and encodes a protein consisting of 493 amino acids with a molecular weight of approximately 54.5 kDa . The protein structure includes four β-trefoil domains, which are responsible for its actin-bundling activity. These domains create three major actin-binding surfaces that facilitate the bundling of actin filaments .

Biological Functions

FSCN1 is involved in several critical cellular functions:

  • Cell Motility and Migration: By bundling actin filaments, FSCN1 enhances the formation of cellular protrusions such as filopodia, which are essential for cell movement and navigation through the extracellular matrix .
  • Cell Adhesion: FSCN1 contributes to the stability of cell-cell and cell-matrix adhesions, playing a role in maintaining tissue integrity .
  • Tumor Invasion and Metastasis: Elevated levels of FSCN1 have been observed in various cancers, where it is associated with increased tumor cell invasiveness and metastatic potential .
Clinical Significance

FSCN1 has garnered significant attention as a potential biomarker and therapeutic target in cancer research. Overexpression of FSCN1 is linked to poor prognosis and aggressive clinical progression in several types of human cancers, including breast, colorectal, and pancreatic cancers . Targeting FSCN1 could potentially inhibit tumor invasion and metastasis, making it a promising candidate for cancer therapy .

Mouse Anti-Human FSCN1 Antibodies

Mouse anti-human FSCN1 antibodies are commonly used in research to study the expression and function of FSCN1 in various biological contexts. These antibodies are utilized in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to detect FSCN1 protein levels and localization in human tissues and cell lines .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.